• menu shortcut
  • contents shortcut
SK biopharmaceuticals
    • CEO Message
    • Vision & Mission
    • History
    • Our Business
    • Network
    • Pipeline Products
    • R&D
    • Key Technologies
    • Startegic Alliance
    • Advisory Board
    • Business Area
    • Key Technologies
    • Career in SK BP
    • Recruiting Board
  • Korean
  • Contact us
  • What's new
  • Sitemap

what's New



Find out more about SK biopharmaceuticals with the latest news.

What's new
no title date
26 SK Biopharmaceuticals Announces U.S. FDA's Authorization of IND for SKL15508 2013.04.17
25 SK Biopharmaceuticals Enters into a Strategic Alliance with SK Chemicals 2013.04.08
24 SK Biopharmaceuticals Announces a Strategic Alliance for Innovative Drug Development with Chinese Biopharmaceutical Companies 2013.03.26
23 SK Biopharmaceuticals Drug Program is Granted Funding Support from Korean Government 2012.12.13
22 SK Biopharmaceuticals Enters into a Licensing Agreement with Hanmi Pharmaceutical 2012.05.03
21 SK Biopharmaceuticals to Initiate Phase 2 Trials in US 2012.03.19
20 SK Bio-Pharmaceuticals Announces New CEO, Dr. Christopher Gallen 2012.03.06
19 SK Biopharmaceuticals Drug Program Wins Funding Support from Korean Government 2012.03.02
18 SK Biopharmaceuticals to Initiate Phase 2 Trials in US 2012.02.22
17 SK biopharmaceuticals Enters into a Licensing Agreement with Premier Chinese Biopharmaceutical Company 2011.11.02
first prev   1 . 2 . 3   next last

What's New

Quick Search

SK biopharmaceuticals

copyright (C) 2011 by SK biopharmaceuticals co. LTD. all rights reservied.